Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theo Daniel Kim

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Safety|December 3, 2010
The expanding role of nilotinib in chronic myeloid leukemiaTheo Daniel Kim, Philipp le Coutre
Expert Review of Hematology|November 19, 2010
Nilotinib for the treatment of chronic myeloid leukemiaTheo Daniel Kim, Bernd Dörken, Philipp le Coutre
Expert Opinion on Pharmacotherapy|September 16, 2011
Omacetaxine mepesuccinate for the treatment of leukemiaTheo Daniel Kim, Mareike Frick, Philipp le Coutre
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 15, 2010
NilotinibAlfonso Quintás-Cardama, Theo Daniel Kim, Vince Cataldo, et al.
Haematologica|November 9, 2004
Prognostic significance of N-RAS and K-RAS mutations in 232 patients with acute myeloid leukemiaMarkus Ritter, Theo Daniel Kim, Petra Lisske, et al.
Gene Expression|December 17, 2005
Distinct gene expression profile of human mesenchymal stem cells in comparison to skin fibroblasts employing cDNA microarray analysis of 9600 genesCornelia Brendel, Larissa Kuklick, Oliver Hartmann, et al.
Leukemia & Lymphoma|May 9, 2008
Expression profiling reveals specific gene expression signatures in gastric MALT lymphomasMinh Quang Huynh, Hans-Heinrich Wacker, Thomas Wündisch, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Safety|December 3, 2010
The expanding role of nilotinib in chronic myeloid leukemiaTheo Daniel Kim, Philipp le Coutre
Expert Review of Hematology|November 19, 2010
Nilotinib for the treatment of chronic myeloid leukemiaTheo Daniel Kim, Bernd Dörken, Philipp le Coutre
Expert Opinion on Pharmacotherapy|September 16, 2011
Omacetaxine mepesuccinate for the treatment of leukemiaTheo Daniel Kim, Mareike Frick, Philipp le Coutre
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 15, 2010
NilotinibAlfonso Quintás-Cardama, Theo Daniel Kim, Vince Cataldo, et al.
Haematologica|November 9, 2004
Prognostic significance of N-RAS and K-RAS mutations in 232 patients with acute myeloid leukemiaMarkus Ritter, Theo Daniel Kim, Petra Lisske, et al.
Gene Expression|December 17, 2005
Distinct gene expression profile of human mesenchymal stem cells in comparison to skin fibroblasts employing cDNA microarray analysis of 9600 genesCornelia Brendel, Larissa Kuklick, Oliver Hartmann, et al.
Leukemia & Lymphoma|May 9, 2008
Expression profiling reveals specific gene expression signatures in gastric MALT lymphomasMinh Quang Huynh, Hans-Heinrich Wacker, Thomas Wündisch, et al.
Pageof 1